Sociodemographic Factors Predict Early Discontinuation of HIV Non-Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors

Podobne knjige/članki

• Pharmacogenetics of nucleoside reverse-transcriptase inhibitor-associated peripheral neuropathy
  od: Kallianpur, Asha R, et al.
  Izdano: (2009)
• A Randomized Trial of Raltegravir Replacement for Protease Inhibitor or Non-Nucleoside Reverse Transcriptase Inhibitor in HIV-Infected Women with Lipohypertrophy
  od: Lake, Jordan E., et al.
  Izdano: (2012)
• Metabolic Abnormalities Associated with the Use of Protease Inhibitors and Non-nucleoside Reverse Transcriptase Inhibitors
  od: Rao, Madhu N., et al.
  Izdano: (2006)
• Use of Protease Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors Among Medicaid Beneficiaries With AIDS
  od: Sambamoorthi, Usha, et al.
  Izdano: (2001)
• Combination Nucleoside/ Nucleotide Reverse Transcriptase Inhibitors
  od: Akanbi, Maxwell O, et al.
  Izdano: (2012)